User profiles for Sunil V Badve
Sunil V. BadveProfessor, UNSW Medicine Verified email at unsw.edu.au Cited by 6719 |
[HTML][HTML] Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer
…, JA Olson Jr, T Lively, SS Badve… - … England Journal of …, 2018 - Mass Medical Soc
Background The recurrence score based on the 21-gene breast cancer assay predicts
chemotherapy benefit if it is high and a low risk of recurrence in the absence of chemotherapy if it …
chemotherapy benefit if it is high and a low risk of recurrence in the absence of chemotherapy if it …
[HTML][HTML] Prospective validation of a 21-gene expression assay in breast cancer
…, JA Zujewski, T Lively, SS Badve… - … England Journal of …, 2015 - Mass Medical Soc
Background Prior studies with the use of a prospective–retrospective design including
archival tumor samples have shown that gene-expression assays provide clinically useful …
archival tumor samples have shown that gene-expression assays provide clinically useful …
[HTML][HTML] Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 …
…, GW Sledge, JA Sparano, SS Badve - Journal of clinical …, 2014 - ncbi.nlm.nih.gov
Purpose Recent studies suggest that tumor-infiltrating lymphocytes (TILs) are associated
with disease-free (DFS) and overall survival (OS) in operable triple-negative breast cancer (…
with disease-free (DFS) and overall survival (OS) in operable triple-negative breast cancer (…
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network …
Objective To evaluate sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like
peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes at varying …
peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes at varying …
Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis
…, M Ruospo, P Natale, V Saglimbene, SV Badve… - Jama, 2016 - jamanetwork.com
Importance Numerous glucose-lowering drugs are used to treat type 2 diabetes. Objective
To estimate the relative efficacy and safety associated with glucose-lowering drugs including …
To estimate the relative efficacy and safety associated with glucose-lowering drugs including …
[HTML][HTML] Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer
…, JA Olson Jr, T Lively, SS Badve… - New England journal …, 2019 - Mass Medical Soc
Background The use of adjuvant chemotherapy in patients with breast cancer may be guided
by clinicopathological factors and a score based on a 21-gene assay to determine the risk …
by clinicopathological factors and a score based on a 21-gene assay to determine the risk …
[HTML][HTML] Effects of allopurinol on the progression of chronic kidney disease
Background Elevated serum urate levels are associated with progression of chronic kidney
disease. Whether urate-lowering treatment with allopurinol can attenuate the decline of the …
disease. Whether urate-lowering treatment with allopurinol can attenuate the decline of the …
[HTML][HTML] ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and …
Introduction: The 2004 version of the World Health Organization classification subdivides
thymic epithelial tumors into A, AB, B1, B2, and B3 (and rare other) thymomas and thymic …
thymic epithelial tumors into A, AB, B1, B2, and B3 (and rare other) thymomas and thymic …
Recent peritonitis associates with mortality among patients treated with peritoneal dialysis
Peritonitis is a major complication of peritoneal dialysis, but the relationship between peritonitis
and mortality among these patients is not well understood. In this case-crossover study, …
and mortality among these patients is not well understood. In this case-crossover study, …
[HTML][HTML] An international study to increase concordance in Ki67 scoring
Although an important biomarker in breast cancer, Ki67 lacks scoring standardization, which
has limited its clinical use. Our previous study found variability when laboratories used their …
has limited its clinical use. Our previous study found variability when laboratories used their …